Clinical Trial

Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical research participation has historically been heavily biased toward specific demographics. This study will invite several participants to gather a wide range of information on clinical trial experiences for squamous cell carcinoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of squamous cell carcinoma. People with squamous cell carcinoma who are invited to take part in clinical research will benefit from the analysis of the data.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05929547
Lead Sponsor Power Life Sciences Inc.
Conditions Squamous Cell Carcinoma
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-07-03